salbutamol cipla salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
salbutamol cipla salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
salbutamol an salbutamol (as sulfate) 5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
salbutamol an salbutamol (as sulfate) 2.5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
ventolin injection
glaxo smith kline (israel) ltd - salbutamol as sulfate - solution for injection - salbutamol as sulfate 0.5 mg/ml - salbutamol - salbutamol - ventolin injection is indicated in adults.ventolin injection provides short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. it is indicated for the relief of severe bronchospasm.
salbutamol sandoz salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
salbutamol sandoz salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
ventolin obstetric 5mg/5ml injection ampoule
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sulfuric acid - for the management of uncomplicated premature labour. to arrest labour between 24 and 33 weeks of gestation in patients with no medical or obstetric contraindication to tocolytic therapy. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.
apo-salbutamol salbutamol 5 mg/ 2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: water for injections; sodium chloride; sulfuric acid - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
apo-salbutamol salbutamol 2.5 mg / 2.5 ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.